Sebastian Teitz PhD Novo Nordisk

Sebastian Teitz graduated from the University of Cologne with a diploma in Genomic Imprinting. He followed this with a PhD in the Analysis of O-glycosylated Proteins. Sebastian has previously worked at Fred Hutchinson Cancer Research Center (Seattle, WA), looking into Cytomegalovirus and its Role in Graft vs. Host Disease and Transplant Rejection; and at NewLab BioQuality / Charles River as the Project Manager of Virus Clearance Studies. Within Asahi, his focus was on virus- & pathogen safety, supporting customers & internal entities technically and scientifically, and being a liaison for authorities, CROs, and industry consortiums of the biopharmaceuticals industry. At Biopharma-Excellence he consulted developers of new drugs in scientific- & regulatory affairs during all stages to market access and is currently Senior Development Scientist at Novo Nordisk, safeguarding Biopharmaceuticals from the risk of virus transmissions to patients.